Full Array of Molecular Capabilities

KCAS Bio has over 100+ years of combined experience in molecular services to support pre-clinical and clinical trials in various species, developing and validating methods and analyzing samples from a wide range of matrices.

Our team has expertise in ddPCR, qPCR, biodistribution studies, molecular genomics, pharmacokinetic/pharmacodynamic (PK/PD), biomarkers, and more.

Our road map to success is simple. KCAS Bio adheres to FDA-GLP.  We operate a world-class, purpose- built, and regulated unidirectional workflow for PCR-based methods that include two dedicated preamplification areas and a dedicated postamplification area to support molecular services. This method allows for no backward reaction movement.

Specifically, KCAS Bio provides comprehensive molecular and genetic analysis services for cell and gene therapies including:

• Viral vector vaccine and oncolytic viral therapies
• Biodistribution and persistence of cell and gene therapies
• Transgene expression of gene therapies
• Detection of copy number variation
• Transgene copy numbers
• Detection of quantification of gene edits in modified cells (VCN)
• Rare sequence/mutation detection
• Gene expression alterations
• Nucleic acid biomarker analysis including rare mRNAs, mRNA, and cell-free DNA
• Cell-based biomarker assays
• Pathogen detection
• Contaminant testing of cell and gene therapy products
• Targeted microbiome analysis

Discover how our molecular and genetic analysis solutions can support your research and development. Partner with us to ensure precision, compliance, and success in your therapeutic advancements. Fill out the form today to discuss your project needs!